Yiannis Monovoukas

Direktor/Vorstandsmitglied bei TheraPten Biosciences, Inc.

Health Technology

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Harvey Lalach	M	57	TheraPten Biosciences, Inc. TheraPten Biosciences, Inc. BiotechnologyHealth Technology TheraPten Biosciences, Inc. develops anti-cancer protein therapeutics. Its PTEN-L, is a natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. The company was founded by Athanassios Alevizopoulos , Harvey Lalach and Ramon Parsons and is headquartered in Kelowna, Canada.	8 Jahre
Athanassios Alevizopoulos	M	-	TheraPten Biosciences, Inc. TheraPten Biosciences, Inc. BiotechnologyHealth Technology TheraPten Biosciences, Inc. develops anti-cancer protein therapeutics. Its PTEN-L, is a natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. The company was founded by Athanassios Alevizopoulos , Harvey Lalach and Ramon Parsons and is headquartered in Kelowna, Canada.	8 Jahre
Ramon Parsons	M	-	TheraPten Biosciences, Inc. TheraPten Biosciences, Inc. BiotechnologyHealth Technology TheraPten Biosciences, Inc. develops anti-cancer protein therapeutics. Its PTEN-L, is a natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. The company was founded by Athanassios Alevizopoulos , Harvey Lalach and Ramon Parsons and is headquartered in Kelowna, Canada.	8 Jahre
Kyriakoulis Paganis	M	-	TheraPten Biosciences, Inc. TheraPten Biosciences, Inc. BiotechnologyHealth Technology TheraPten Biosciences, Inc. develops anti-cancer protein therapeutics. Its PTEN-L, is a natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. The company was founded by Athanassios Alevizopoulos , Harvey Lalach and Ramon Parsons and is headquartered in Kelowna, Canada.	-